Very exciting news! The only point of note is where Paul says,
'"Additionally, the data generated will form part of Paradigm’s submission package to the TGA for the next step of the provisional approval application". This tells me TGA approvals won't be until later in the year. DYOR
Ann: Paradigm doses first participant in Synovial Fluid Trial, page-14
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
24.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $85.70M | |||
| Open | High | Low | Value | Volume |
| 24.5¢ | 24.5¢ | 24.5¢ | $1.03K | 4.205K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 5841 | 24.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 25.0¢ | 4889 | 3 |
View Market Depth
| Last trade - 10.42am 02/09/2024 (20 minute delay) ? |
| PAR (ASX) Chart |